MAPT and Parkinson disease: Liu et al. followed up the cognitive decline of PD patients for 4.3 years after the initiation of levodopa and found that CSF phosphorylated tau (p-tau) and the p-tau:Aβ42 ratio predict subsequent decline on cognitive tasks involving both memory and executive functions [223].